Results 281 to 290 of about 79,270 (300)

Phosphodiesterase Type 5 Inhibitors

2009
openaire   +1 more source

Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies

Ca-A Cancer Journal for Clinicians, 2018
David A Mahvi, Rong Liu, Yolonda L Colson   +2 more
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Phosphodiesterase type-5 inhibitors

2016
openaire   +1 more source

Cancer of the esophagus and esophagogastric junction—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Deepa T Patil, David P Kelsen
exaly  

Implementing personalized pathways for cancer follow‐up care in the United States: Proceedings from an American Cancer Society–American Society of Clinical Oncology summit

Ca-A Cancer Journal for Clinicians, 2019
Catherine M Alfano, Smita Bhatia, Jessica M Scott   +2 more
exaly  

Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications

Ca-A Cancer Journal for Clinicians, 2014
William W Tseng
exaly  

Editorial: Tachyphylaxis and Phosphodiesterase Type 5 Inhibitors

The Journal of Urology, 2002
openaire   +1 more source

Cancer Epigenetics

Ca-A Cancer Journal for Clinicians, 2010
Jean-Pierre J Issa
exaly  

Risk factors, pathophysiology, and treatment of hot flashes in cancer

Ca-A Cancer Journal for Clinicians, 2013
Gary R Elkins, Debra S Burns, Menggang Yu   +2 more
exaly